These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25206413)

  • 1. Are human dental papilla-derived stem cell and human brain-derived neural stem cell transplantations suitable for treatment of Parkinson's disease?
    Yoon HH; Min J; Shin N; Kim YH; Kim JM; Hwang YS; Suh JK; Hwang O; Jeon SR
    Neural Regen Res; 2013 May; 8(13):1190-200. PubMed ID: 25206413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced efficacy of human brain-derived neural stem cells by transplantation of cell aggregates in a rat model of Parkinson's disease.
    Shin ES; Hwang O; Hwang YS; Suh JK; Chun YI; Jeon SR
    J Korean Neurosurg Soc; 2014 Nov; 56(5):383-9. PubMed ID: 25535514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease.
    Xu JT; Qian Y; Wang W; Chen XX; Li Y; Li Y; Yang ZY; Song XB; Lu D; Deng XL
    Neural Regen Res; 2020 Jan; 15(1):112-119. PubMed ID: 31535659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regenerative medicine for Parkinson's disease using differentiated nerve cells derived from human buccal fat pad stem cells.
    Takahashi H; Ishikawa H; Tanaka A
    Hum Cell; 2017 Apr; 30(2):60-71. PubMed ID: 28210976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson's disease.
    Wang F; Cheng XY; Zhang YT; Bai QR; Zhang XQ; Sun XC; Ma QH; Zhao XF; Liu CF
    Open Life Sci; 2024; 19(1):20220834. PubMed ID: 38465343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
    Gu S; Huang H; Bi J; Yao Y; Wen T
    Brain Res; 2009 Feb; 1257():1-9. PubMed ID: 19111525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.
    Hovakimyan M; Haas SJ; Schmitt O; Gerber B; Wree A; Andressen C
    J Anat; 2006 Dec; 209(6):721-32. PubMed ID: 17118060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum.
    Yoon HH; Kim YH; Shin ES; Jeon SR
    J Korean Med Sci; 2014 Nov; 29(11):1555-61. PubMed ID: 25408589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model.
    Shyu WC; Li KW; Peng HF; Lin SZ; Liu RS; Wang HJ; Su CY; Lee YJ; Li H
    J Neurosci Res; 2009 Jul; 87(9):2020-33. PubMed ID: 19235891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
    Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
    Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT.
    Park BN; Kim JH; Lee K; Park SH; An YS
    Eur Radiol; 2015 May; 25(5):1487-96. PubMed ID: 25504429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.
    Yasuhara T; Matsukawa N; Hara K; Yu G; Xu L; Maki M; Kim SU; Borlongan CV
    J Neurosci; 2006 Nov; 26(48):12497-511. PubMed ID: 17135412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts.
    Chiu CH; Li IH; Weng SJ; Huang YS; Wu SC; Chou TK; Huang WS; Liao MH; Shiue CY; Cheng CY; Ma KH
    Cell Transplant; 2016; 25(2):301-11. PubMed ID: 25994923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain.
    Araki T; Tanji H; Kato H; Imai Y; Mizugaki M; Itoyama Y
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):365-75. PubMed ID: 10974608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA
    Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
    Bagga V; Dunnett SB; Fricker RA
    Behav Brain Res; 2015 Jul; 288():107-17. PubMed ID: 25841616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.